Claire Kowalick

Shared by Claire Kowalick For the past decade, adolescent mental health disorders have skyrocketed, an issue propelled even further by the COVID-19 pandemic.

UT Health San Antonio urologist discovers combined anti-seizure drug and omega-3 may lower COVID-19 risks

Ronald Rodriguez, MD, Ph.D., professor of medical education and urology at Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has discovered that the combination of valproic acid and docosahexaenoic acid (DHA) may reduce the risk of contracting COVID-19 and lessen its severity, according to a study published in August.

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from

Shared by Claire Kowalick Charles P. France, PhD, to lead methocinnamox drug development program

Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse.

Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function.

In the study of uncommon congenital disorders, collaboration is key to potential new insights and discoveries. The Gabriella Miller Kids First Pediatric Research Program Data Resource Center announced in September the public release of three comprehensive datasets related to childhood cancers and congenital disorders, one of which was provided by The University of Texas Health Science Center at San Antonio (UT Health San Antonio).

The race to draw the best and brightest students has become an international one, with candidates weighing options not only in their state or country, but also across the globe. Universities likewise face fierce competition globally for top scientists and research funding.

A new study by researchers at the universities of Texas and Chicago explains the enzymatic activity that’s needed for tumor suppression in leukemias and other cancers.